GB201510357D0 - Adenovirus polynucleotides and polypeptides - Google Patents

Adenovirus polynucleotides and polypeptides

Info

Publication number
GB201510357D0
GB201510357D0 GBGB1510357.5A GB201510357A GB201510357D0 GB 201510357 D0 GB201510357 D0 GB 201510357D0 GB 201510357 A GB201510357 A GB 201510357A GB 201510357 D0 GB201510357 D0 GB 201510357D0
Authority
GB
United Kingdom
Prior art keywords
polypeptides
adenovirus
polynucleotides
adenovirus polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1510357.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB1510357.5A priority Critical patent/GB201510357D0/en
Publication of GB201510357D0 publication Critical patent/GB201510357D0/en
Priority to EP16730315.5A priority patent/EP3307313A1/en
Priority to PCT/EP2016/063329 priority patent/WO2016198621A1/en
Priority to EA201792651A priority patent/EA038402B9/en
Priority to JP2017564467A priority patent/JP6873054B2/en
Priority to CN201680047373.1A priority patent/CN107921118B/en
Priority to PCT/EP2016/063297 priority patent/WO2016198599A1/en
Priority to AU2016275601A priority patent/AU2016275601A1/en
Priority to CA2988654A priority patent/CA2988654A1/en
Priority to AU2016275619A priority patent/AU2016275619B2/en
Priority to KR1020187000991A priority patent/KR20180012857A/en
Priority to KR1020177037436A priority patent/KR102535670B1/en
Priority to BE2016/5434A priority patent/BE1024420B1/en
Priority to US15/735,839 priority patent/US11254710B2/en
Priority to EP16730773.5A priority patent/EP3307314A1/en
Priority to CA2988481A priority patent/CA2988481A1/en
Priority to BE2016/5433A priority patent/BE1024824B1/en
Priority to MX2017016105A priority patent/MX2017016105A/en
Priority to BR112017026523A priority patent/BR112017026523A2/en
Priority to JP2017564424A priority patent/JP6983665B2/en
Priority to ARP160101736A priority patent/AR104966A1/en
Priority to CN201680047775.1A priority patent/CN108025058B/en
Priority to US15/735,872 priority patent/US11254711B2/en
Priority to MX2017016101A priority patent/MX2017016101A/en
Priority to ARP160101737A priority patent/AR104967A1/en
Priority to ZA2017/08159A priority patent/ZA201708159B/en
Priority to IL256069A priority patent/IL256069B2/en
Priority to IL256121A priority patent/IL256121B2/en
Priority to AU2019202081A priority patent/AU2019202081B2/en
Priority to AU2019271972A priority patent/AU2019271972B2/en
Priority to US17/565,796 priority patent/US20220204566A1/en
Priority to US17/583,511 priority patent/US20220220157A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
GBGB1510357.5A 2015-06-12 2015-06-12 Adenovirus polynucleotides and polypeptides Ceased GB201510357D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
GBGB1510357.5A GB201510357D0 (en) 2015-06-12 2015-06-12 Adenovirus polynucleotides and polypeptides
BE2016/5433A BE1024824B1 (en) 2015-06-12 2016-06-10 POLYNUCLEOTIDES AND POLYPEPTIDES OF ADENOVIRUS
EP16730773.5A EP3307314A1 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
MX2017016101A MX2017016101A (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides.
EA201792651A EA038402B9 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
JP2017564467A JP6873054B2 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
CN201680047373.1A CN107921118B (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
PCT/EP2016/063297 WO2016198599A1 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
MX2017016105A MX2017016105A (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides.
CA2988654A CA2988654A1 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
AU2016275619A AU2016275619B2 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
KR1020187000991A KR20180012857A (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
KR1020177037436A KR102535670B1 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
BE2016/5434A BE1024420B1 (en) 2015-06-12 2016-06-10 POLYNUCLEOTIDES AND POLYPEPTIDES OF ADENOVIRUS
US15/735,839 US11254710B2 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
EP16730315.5A EP3307313A1 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
CA2988481A CA2988481A1 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
ARP160101737A AR104967A1 (en) 2015-06-12 2016-06-10 ISOLATED POLINUCLEOTIDE, RECOMBINANT VECTOR, RECOMBINANT ADENOVIRUS AND COMPOSITION THAT INCLUDE IT AND ITS USE TO PREPARE A MEDICINAL PRODUCT
AU2016275601A AU2016275601A1 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
BR112017026523A BR112017026523A2 (en) 2015-06-12 2016-06-10 recombinant vector, recombinant adenovirus, composition, use of a recombinant vector, recombinant adenovirus or composition, method for inducing an immune response in an individual, and isolated polynucleotide.
JP2017564424A JP6983665B2 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
ARP160101736A AR104966A1 (en) 2015-06-12 2016-06-10 ISOLATED POLINUCLEOTIDE, RECOMBINATING POLINUCLEOTIDE, RECOMBINING VECTOR AND RECOMBINANT ADENOVIRUS AND CELL THAT UNDERSTAND IT, COMPOSITION THAT UNDERSTANDS AND CODED BY THE SAME POLYPEPTIDE
CN201680047775.1A CN108025058B (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
US15/735,872 US11254711B2 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
PCT/EP2016/063329 WO2016198621A1 (en) 2015-06-12 2016-06-10 Adenovirus polynucleotides and polypeptides
ZA2017/08159A ZA201708159B (en) 2015-06-12 2017-11-30 Adenovirus polynucleotides and polypeptides
IL256069A IL256069B2 (en) 2015-06-12 2017-12-03 Adenovirus polynucleotides and polypeptides
IL256121A IL256121B2 (en) 2015-06-12 2017-12-05 Adenovirus polynucleotides and polypeptides
AU2019202081A AU2019202081B2 (en) 2015-06-12 2019-03-26 Adenovirus polynucleotides and polypeptides
AU2019271972A AU2019271972B2 (en) 2015-06-12 2019-11-27 Adenovirus polynucleotides and polypeptides
US17/565,796 US20220204566A1 (en) 2015-06-12 2021-12-30 Adenovirus polynucleotides and polypeptides
US17/583,511 US20220220157A1 (en) 2015-06-12 2022-01-25 Adenovirus polynucleotides and polypeptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1510357.5A GB201510357D0 (en) 2015-06-12 2015-06-12 Adenovirus polynucleotides and polypeptides

Publications (1)

Publication Number Publication Date
GB201510357D0 true GB201510357D0 (en) 2015-07-29

Family

ID=53784650

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1510357.5A Ceased GB201510357D0 (en) 2015-06-12 2015-06-12 Adenovirus polynucleotides and polypeptides

Country Status (2)

Country Link
AR (2) AR104967A1 (en)
GB (1) GB201510357D0 (en)

Also Published As

Publication number Publication date
AR104967A1 (en) 2017-08-30
AR104966A1 (en) 2017-08-30

Similar Documents

Publication Publication Date Title
IL256121A (en) Adenovirus polynucleotides and polypeptides
IL275307B (en) Syntac polypeptides and uses thereof
IL266942A (en) Adenovirus polynucleotides and polypeptides
ZA201802261B (en) Polypeptides
IL274217A (en) Adenovirus and uses thereof
IL274219A (en) Adenovirus and uses thereof
HK1250041A1 (en) Polypeptides
GB201713765D0 (en) Modified adenovirus
ZA201704366B (en) Il-17a-binding polypeptides
HK1250040A1 (en) Polypeptides
IL274220A (en) Adenovirus and uses thereof
GB201410031D0 (en) Polypeptides and uses thereof
IL258897A (en) Polypeptides against il-23
ZA201708159B (en) Adenovirus polynucleotides and polypeptides
GB201514772D0 (en) Adenovirus polynucleotides and polypeptides
GB201510357D0 (en) Adenovirus polynucleotides and polypeptides
GB201614607D0 (en) Modified adenovirus
GB201706219D0 (en) Modified adenovirus
GB201700663D0 (en) Modified adenovirus
GB201511958D0 (en) Polypeptides, polynucleotides and uses thereof
GB201613143D0 (en) Polypeptides and uses thereof
GB201613142D0 (en) Polypeptides and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)